We are live on ! Find out more
JPMIA

J.P. Marvel Investment Advisors Portfolio holdings

AUM $871M
1-Year Est. Return 64.45%
This Fund
S&P 500
This Quarter Est. Return
+10.6%
1 Year Est. Return
+64.45%
3 Year Est. Return
+183.15%
5 Year Est. Return
+262.44%
10 Year Est. Return
AUM
$505M
AUM Growth
+$40.3M
Cap. Flow
-$3.98M
Cap. Flow %
-0.79%
Top 10 Hldgs %
50.94%
Holding
73
New
4
Increased
2
Reduced
45
Closed
2

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$2.48M
2
CVS icon
CVS Health
CVS
+$836K
3
VLTO icon
Veralto
VLTO
+$792K
4
AVGO icon
Broadcom
AVGO
+$556K
5
INTC icon
Intel
INTC
+$235K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.67M
2
AES icon
AES
AES
+$1.16M
3
DHR icon
Danaher
DHR
+$1.03M
4
VMW
VMware, Inc
VMW
+$791K
5
F icon
Ford
F
+$706K

Sector Composition

Rank Sector Weight
1 Technology 31.63%
2 Healthcare 28.68%
3 Financials 12.57%
4 Communication Services 6.4%
5 Industrials 5.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AWK icon
26
American Water Works
AWK
$26.9B
$5.97M 1.18%
45,234
-60
-0.1% -$7.57K
INTC icon
27
Intel
INTC
$513B
$5.94M 1.18%
118,157
+5,795
+5% +$235K
CVS icon
28
CVS Health
CVS
$122B
$5.37M 1.06%
67,964
+11,740
+21% +$836K
MDT icon
29
Medtronic
MDT
$112B
$4.74M 0.94%
57,536
ITCI
30
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$4.65M 0.92%
64,886
-270
-0.4% -$15.5K
MRNA icon
31
Moderna
MRNA
$23.6B
$4.58M 0.91%
46,037
-75
-0.2% -$6.31K
PFE icon
32
Pfizer
PFE
$153B
$4.51M 0.89%
156,704
-55,340
-26% -$1.67M
MRK icon
33
Merck
MRK
$318B
$4.4M 0.87%
40,350
-160
-0.4% -$16.6K
CLH icon
34
Clean Harbors
CLH
$16.3B
$4.26M 0.84%
24,417
-290
-1% -$47.6K
XOM icon
35
ExxonMobil
XOM
$634B
$4.11M 0.81%
41,128
-1,200
-3% -$126K
KO icon
36
Coca-Cola
KO
$375B
$3.92M 0.78%
66,589
-889
-1% -$50.5K
CAT icon
37
Caterpillar
CAT
$387B
$3.6M 0.71%
12,169
-155
-1% -$40.2K
CNC icon
38
Centene
CNC
$32.5B
$3.41M 0.68%
45,915
-900
-2% -$64.9K
IBM icon
39
IBM
IBM
$224B
$3.25M 0.64%
19,855
-20
-0.1% -$3.02K
CARR icon
40
Carrier Global
CARR
$52.8B
$3.23M 0.64%
56,305
-210
-0.4% -$11.1K
HES
41
DELISTED
Hess
HES
$3.14M 0.62%
21,777
-120
-0.5% -$17.6K
GE icon
42
GE Aerospace
GE
$384B
$3.13M 0.62%
30,750
AMD icon
43
Advanced Micro Devices
AMD
$789B
$2.88M 0.57%
19,550
ADBE icon
44
Adobe
ADBE
$105B
$2.56M 0.51%
+4,299
New +$2.48M
VRTX icon
45
Vertex Pharmaceuticals
VRTX
$126B
$2.53M 0.5%
6,220
CMCSA icon
46
Comcast
CMCSA
$90B
$2.42M 0.48%
55,274
-660
-1% -$28.3K
MCD icon
47
McDonald's
MCD
$195B
$2.28M 0.45%
7,700
-189
-2% -$51.4K
SBUX icon
48
Starbucks
SBUX
$120B
$2.05M 0.41%
21,300
-580
-3% -$56.5K
OTIS icon
49
Otis Worldwide
OTIS
$28.2B
$1.93M 0.38%
21,604
-465
-2% -$38.7K
TXN icon
50
Texas Instruments
TXN
$261B
$1.73M 0.34%
10,160

Similar funds

J.P. Marvel Investment Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, J.P. Marvel Investment Advisors held 73 positions worth $505M, up 8.7% from $464M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

J.P. Marvel Investment Advisors's Q4 2023 filing shows 4 new, 2 increased, 45 reduced and 2 closed positions. Its largest new stake was Adobe: 4,299 shares worth $2.56M. The largest sale was Pfizer, an estimated $1.67M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • J.P. Marvel Investment Advisors's largest Q4 2023 buy was Adobe: 4,299 shares worth $2.56M.
  • J.P. Marvel Investment Advisors added most to CVS Health in Q4 2023, an estimated $836K increase.
  • J.P. Marvel Investment Advisors's biggest Q4 2023 reduction was Pfizer, cutting an estimated $1.67M.
  • J.P. Marvel Investment Advisors fully exited AES in Q4 2023, selling an estimated $1.16M.
  • J.P. Marvel Investment Advisors's ten largest holdings make up 51% of its $505M portfolio in Q4 2023.
  • J.P. Marvel Investment Advisors opened 4 new positions and closed 2 in Q4 2023.
  • J.P. Marvel Investment Advisors's portfolio value rose 8.7% quarter-over-quarter to $505M.

Based on J.P. Marvel Investment Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.